Clinical Trials Logo

Fasting clinical trials

View clinical trials related to Fasting.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05457530 Withdrawn - Obesity Clinical Trials

Doravirine and Weight Gain in Antiretroviral Naive

DAWN
Start date: August 1, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is determine whether different antiretroviral therapy (ART) changes the effects on body fat and predict the weight change in Black and Hispanic females.

NCT ID: NCT04842864 Withdrawn - Fasting Clinical Trials

Time Course for Fasting-induced Autophagy in Humans

Start date: November 19, 2021
Phase: N/A
Study type: Interventional

Autophagy, which involves the degradation of aged or damaged cellular components, has been shown to extend healthspan and lifespan in multiple organisms, including flies, worms, and mice. Research has also demonstrated that autophagy declines with age in these simpler experimental models. However, human studies are lacking. Our study seeks to determine whether fasting, a robust stimulus of autophagy, upregulates autophagy in humans, and whether autophagy is reduced in healthy older people compared to healthy younger individuals.

NCT ID: NCT02957435 Withdrawn - Healthy Subjects Clinical Trials

Pharmacokinetics Study of Eplerenone Coated Tablets

Start date: July 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics profile of the formulation of eplerenone coated tablets in the concentration of 25mg, 50mg and 100mg (2 coated tablets of 50mg) in male and female healthy subjects under fasting condition.

NCT ID: NCT02396446 Withdrawn - Fasting Clinical Trials

AbStats at the Bedside: Improving Patient Feeding Decisions Using an Abdominal Acoustic Score

Start date: June 2017
Phase:
Study type: Observational

This study is being conducted to determine whether providers who have access to their patients' acoustic intestinal rate score as calculated by an abdominal acoustic sensor that continuously monitors bowel sounds (AbStats) will be more likely to advance their patients' diets to a solid diet sooner than those who do not have access to this rate. AbStats calculates intestinal rates by using two small sensors placed on a patient's abdomen to measure and analyze their abdominal sounds. Patients will be asked to wear a sensor every morning for 20 minutes while they are fasting daily during their inpatient visit. The sensor will measure the sounds within their abdomen. This data will be interpreted by the AbStats device, which will provide an intestinal rate measurement based on the sounds recorded by the sensors. This intestinal rate will be provided to the patient's treating physician together with other vital signs. The doctor, at his/her discretion, may choose to use this information to make decisions about the patient's feeding status.